315 related articles for article (PubMed ID: 32051695)
1. New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis.
Pagani S; Bellan M; Mauro D; Castello LM; Avanzi GC; Lewis MJ; Sainaghi PP; Pitzalis C; Nerviani A
Dis Markers; 2020; 2020():1614627. PubMed ID: 32051695
[TBL] [Abstract][Full Text] [Related]
2. Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis.
Waterborg CEJ; Koenders MI; van Lent PLEM; van der Kraan PM; van de Loo FAJ
PLoS One; 2018; 13(10):e0205902. PubMed ID: 30335822
[TBL] [Abstract][Full Text] [Related]
3. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
Tsou WI; Nguyen KQ; Calarese DA; Garforth SJ; Antes AL; Smirnov SV; Almo SC; Birge RB; Kotenko SV
J Biol Chem; 2014 Sep; 289(37):25750-63. PubMed ID: 25074926
[TBL] [Abstract][Full Text] [Related]
4. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
Elife; 2014 Sep; 3():. PubMed ID: 25265470
[TBL] [Abstract][Full Text] [Related]
5. Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis.
Gao L; He C; Yang A; Zhou H; Lu Q; Birge RB; Wu Y
Cell Commun Signal; 2023 Aug; 21(1):195. PubMed ID: 37537628
[TBL] [Abstract][Full Text] [Related]
6. TAM receptors in phagocytosis: Beyond the mere internalization of particles.
Burstyn-Cohen T; Fresia R
Immunol Rev; 2023 Oct; 319(1):7-26. PubMed ID: 37596991
[TBL] [Abstract][Full Text] [Related]
7. TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting.
Peeters MJW; Rahbech A; Thor Straten P
Cancer Immunol Immunother; 2020 Feb; 69(2):237-244. PubMed ID: 31664482
[TBL] [Abstract][Full Text] [Related]
8. The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.
Shafit-Zagardo B; Gruber RC; DuBois JC
Pharmacol Ther; 2018 Aug; 188():97-117. PubMed ID: 29514053
[TBL] [Abstract][Full Text] [Related]
9. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer.
Schmitz R; Valls AF; Yerbes R; von Richter S; Kahlert C; Loges S; Weitz J; Schneider M; Ruiz de Almodovar C; Ulrich A; Schmidt T
Oncotarget; 2016 Aug; 7(35):56355-56370. PubMed ID: 27486820
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer.
Zagórska A; Través PG; Jiménez-García L; Strickland JD; Oh J; Tapia FJ; Mayoral R; Burrola P; Copple BL; Lemke G
Life Sci Alliance; 2020 Aug; 3(8):. PubMed ID: 32571802
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis.
van den Brand BT; Abdollahi-Roodsaz S; Vermeij EA; Bennink MB; Arntz OJ; Rothlin CV; van den Berg WB; van de Loo FA
Arthritis Rheum; 2013 Mar; 65(3):671-80. PubMed ID: 23203851
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of TAM tyrosine kinase receptors and ligands in endometrial carcinoma: An in silico-study.
Dilara Fatma Akin ; Özkan D
Taiwan J Obstet Gynecol; 2023 Mar; 62(2):311-324. PubMed ID: 36965901
[TBL] [Abstract][Full Text] [Related]
13. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.
Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y
Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554
[TBL] [Abstract][Full Text] [Related]
14. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.
Brown JE; Krodel M; Pazos M; Lai C; Prieto AL
PLoS One; 2012; 7(5):e36800. PubMed ID: 22606290
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.
Kasikara C; Kumar S; Kimani S; Tsou WI; Geng K; Davra V; Sriram G; Devoe C; Nguyen KN; Antes A; Krantz A; Rymarczyk G; Wilczynski A; Empig C; Freimark B; Gray M; Schlunegger K; Hutchins J; Kotenko SV; Birge RB
Mol Cancer Res; 2017 Jun; 15(6):753-764. PubMed ID: 28184013
[TBL] [Abstract][Full Text] [Related]
16. TAM receptor tyrosine kinase function and the immunopathology of liver disease.
Mukherjee SK; Wilhelm A; Antoniades CG
Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G899-905. PubMed ID: 26867565
[TBL] [Abstract][Full Text] [Related]
17. TAM receptors in cardiovascular disease.
McShane L; Tabas I; Lemke G; Kurowska-Stolarska M; Maffia P
Cardiovasc Res; 2019 Jul; 115(8):1286-1295. PubMed ID: 30980657
[TBL] [Abstract][Full Text] [Related]
18. TAM receptors and their ligand-mediated activation: Role in atherosclerosis.
Cai B; Kasikara C
Int Rev Cell Mol Biol; 2020; 357():21-33. PubMed ID: 33234243
[TBL] [Abstract][Full Text] [Related]
19. Biology of the TAM receptors.
Lemke G
Cold Spring Harb Perspect Biol; 2013 Nov; 5(11):a009076. PubMed ID: 24186067
[TBL] [Abstract][Full Text] [Related]
20. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
